Bayer AG News and Global Life Sciences & Healthcare Innovation Updates

  • Ciaran Ryan
  • 28.05.2026
Bayer faces U.S. antitrust suit over GMO corn seed market
A new private antitrust case is intensifying scrutiny of competition in the U.S. agricultural inputs sector as farmers contend with persistently high seed and fertilizer costs. The lawsuit accuses ...
  • Ashutosh Sureka
  • 20.05.2026
Bayer CropScience drops seed loyalty provisions after U.S. antitrust scrutiny
Federal antitrust scrutiny of corn and soybean seed markets is prompting changes to Bayer CropScience LLC's commercial terms with independent seed companies. The company has removed provisions the ...
  • Dmytro Kharkov
  • 22.10.2025
BAYN news live: volatility moderate — oscillators warn of weak short-term strength
Bayer AG (BAYN) is currently priced at $27.58, trading just below both the MA-20 ($27.80) and MA-50 ($27.83), but remains well above the MA-200 ($24.96). This configuration indicates short- and ...
  • Dmytro Kharkov
  • 21.10.2025
Bayer consolidates near $27.39, after momentum oscillators signal oversold conditions
Bayer AG (BAYN) trades at $27.39, sitting below both the MA-20 ($27.80) and MA-50 ($27.80), but still above the MA-200 ($24.92). This configuration suggests short- and medium-term bearish ...
  • Dmytro Kharkov
  • 20.10.2025
Q3 results anticipation — Bayer price forecast signals 1.73% gain amid mixed momentum
Bayer AG (BAYN) is currently trading at $27.28, showing a daily gain of $0.47 or 1.73%. The price remains below both the MA-20 at $27.80 and MA-50 at $27.76, but is well supported above the MA-200 ...